D
David M. Wood
Researcher at Guy's and St Thomas' NHS Foundation Trust
Publications - 289
Citations - 10060
David M. Wood is an academic researcher from Guy's and St Thomas' NHS Foundation Trust. The author has contributed to research in topics: Recreational Drug & Recreational drug use. The author has an hindex of 54, co-authored 263 publications receiving 8654 citations. Previous affiliations of David M. Wood include National Health Service & St George's, University of London.
Papers
More filters
Journal ArticleDOI
Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease
Emma H. Baker,Christopher H Janaway,Barbara J. Philips,Amanda L. Brennan,Deborah L. Baines,David M. Wood,Paul W. Jones +6 more
TL;DR: Increasing blood glucose concentrations are associated with adverse clinical outcomes in patients with AECOPD and the risk of adverse outcomes increased with increasing hyperglycaemia independent of age, sex, a previous diagnosis of diabetes, and COPD severity.
Journal ArticleDOI
2,4-Dinitrophenol (DNP): A Weight Loss Agent with Significant Acute Toxicity and Risk of Death
Johann Grundlingh,Paul I. Dargan,Paul I. Dargan,Marwa El-Zanfaly,David M. Wood,David M. Wood +5 more
TL;DR: The pattern and pathophysiology of DNP toxicity is described, the previous fatalities associated with exposure to DNP are summarised and the current and previous fatalities related to exposure are summarized.
Journal ArticleDOI
Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change.
TL;DR: It is shown in this study that the use of mephedrone among school and college/university students is common and that users found it easy to obtain and that there was a high prevalence of unwanted effects associated with its use.
Journal ArticleDOI
Purchasing ‘legal highs’ on the Internet—is there consistency in what you get?
Susannah Davies,David M. Wood,Gina Smith,Jenny Button,J. Ramsey,Roland P. Archer,David W. Holt,Paul I. Dargan +7 more
TL;DR: There was significant variation in the piperazine or cathinone content of one quarter of the legal highs supplied over 6 month, which could be of clinical significance as the cathin one and p Piperazine products can be associated with significant toxicity.
Journal ArticleDOI
Case series of individuals with analytically confirmed acute mephedrone toxicity.
David M. Wood,Susannah Davies,S L Greene,Jenny Button,David W. Holt,John Ramsey,Paul I. Dargan +6 more
TL;DR: These analytically confirmed acute mephedrone toxicity presentations had clinical features of toxicity consistent with an acute sympathomimetic toxidrome, similar to the pattern of toxicity seen with other sympathominetic recreational drugs such as 3,4-Methylenedioxymethamphetamine and cocaine.